{
    "medicine_id": "cb9ac0a65952a288b88b4fbb7a019edb19141967",
    "platform_id": "DB10771",
    "metadata": {
        "name": "CyFolex Cellular sheet",
        "composition": "Bovine type I collagen",
        "clinical_particulars": {
            "therapeutic_indications": "For the management of wounds including partial and full thickness wounds pressure ulcers venous ulcers diabetic ulcers chronic vascular ulcers tunneled undermined wounds surgical wounds donor sites graft post Moh s dermatological surgery post laser surgery podiatric wound dehiscence trauma wounds abrasions lacerations second degree burns and skin tears and draining wounds L2500 Gintuit Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen is an allogeneic cellularized scaffold product indicated for topical non submerged application to a surgically created vascular wound bed in the treatment of mucogingival conditions in adults It uses bovine collagen as a matrix to support the growth of keratinocytes and fibroblasts in wound healing L2450 Other products using bovine type 1 collagen include PriMatrix Integra Orcel and Matriderm L2490 Orcel is a bilayered cellular matrix in which normal human allogeneic skin cells both epidermal keratinocytes and dermal fibroblasts are cultured in two separate layers into a Type I bovine collagen sponge indicated in venous leg ulcers and diabetic foot Type I bovine collagen acts as a matrix for the growth and proliferation of fibroblasts and keratinocytes offering structure and support L2427 In the laboratory bovine Collagen Type I purified protein standard is used as a control for SDS PAGE Western Blot ELISA immunoprecipitation and for other immunological assays L2488",
            "contraindications": {
                "disease": "Elevated anti collagen antibody levels have been detected in patients treated with clinical doses of injectable collagen even in the absence of adverse cutaneous reactions A32697 Antibodies to both native type I bovine and human collagen can lead to a variety of symptoms including joint inflammation edema at the injection site of bovine collagen implant and fever as late as 6 months after injection A32702 A32703 Products derived from bovine tissues especially gelatine tallow and dicalcium phosphate have been studied in relation to bovine spongiform encephalopathy BSE and Creutzfeld Jacob disease CJD A32698 The risk of BSE and CJD is dependent on many factors including the country of origin of the bovine collagen the health of the cattle from which the collagen is obtained and practices during processing Denaturation temperature is a particularly important parameter depending on the collagen origin and hydration level A32699 According to the World Health Organization WHO prolonged alkaline treatment filtration and heat sterilization 138o C for 4 sec or an equivalent process on gelatin is a safe practice in preventing BSE L2497 The collagen manufacturing process may have some steps in common with the manufacture of gelatin such as alkaline and sodium sulfate treatment calcium hydroxide and sodium hydroxide treatments or enzyme treatment These common steps can however differ in duration and pH condition which can result in significant differences in their prion inactivation capacity Manufacturers should at least conduct a process evaluation based on the similarities of the collagen processing steps as compared to known inactivation steps in the manu facture of gelatin to support the safety of the product Outside of the processing steps differences also exist in the final use of the material and as a result in their risk assessment while gelatin is widely used for oral administration many collagen applications are in the form of implants This should be considered in the final risk assessment of type I bovine collagen products L2498 According to the EMA European medicines agency collagen produced from tissues such as hides skins tendons and sinews do not usually present a measurable TSE risk provided that contamination with potentially infected materials for example spillage of blood and or central nervous tissues is avoided during procurement Hides represent a safer raw material for human implants derived from collagen However cross contamination with brain material released during the slaughtering process possibly dried on the surface of hides is difficult to eliminate This is another aspect to consider in the evaluation of the safety of bovine type I collagen L2497",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Collagen based ingredients are very important for tissue engineering and regenerative medicine because of its superior human biocompatibility and low immunogenicity L2492 Bovine Collagen Type I belongs to a family of proteins found particularly in the flesh and connective tissues of mammals approximately 1 3 of the body s total protein More than two dozen types of collagen have been discovered Type I is the most abundant form in the body This type of collagen is found in scar tissue tendons the skin arterial wall the cornea muscles cartilage and in certain parts of bones and teeth Bovine Collagen Type I is ideal for investigators studying in extracellular matrix proteins and osteoporosis L2488 Type I collagen is the primary organic component of the extracellular matrix in the bone and can play an imperative role in bone tissue engineering Type I collagen bovine is the basis of several laboratory and pharmaceutical products including Collapat II Healos Collagraft and Biostite among others L2489",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}